Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...
NEW YORK, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (PBM) ("Psyence Biomed" or the "Company") is pleased to provide an update on its previously-announced pending strategic acquisition ...
Our Bureau, Bengaluru Tuesday, January 20, 2026, 16:30 Hrs [IST] ...
The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...
SEATTLE--(BUSINESS WIRE)--Pluristyx, a leading provider of Good Manufacturing Practices (GMP), cutting-edge, induced pluripotent stem cell (iPSC) technologies, today announced the immediate ...
HRV Global Life Sciences (HRV Pharma), India’s first integrated Virtual API and Pharmtech company, entered into a comprehensive, multi-year contract development & manufacturing (CDMO) partnership with ...
VANCOUVER, British Columbia, Jan. 21, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (HYTNF) (“HYTN” or the “Company”), a company specializing in pharmaceutical-grade cannabis manufacturing, is ...
The launch of the GMP PSXi013 iPSC Master Cell Bank marks a pivotal moment in Pluristyx's ongoing mission to accelerate the development of stem cell therapies. By providing a high-quality, low-passage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results